Venous Thrombosis, Oral Contraceptives and High Factor VIII Levels

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Thrombosis and Haemostasis

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1614323PMID 10494758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.

  1998cited by this paper
• Familial Clustering of Factor VIII and von Willebrand Factor Levels

  1998cited by this paper
• High Prevalence of Elevated Factor VIII Levels in Patients Referred for Thrombophilia Screening: Role of Increased Synthesis and Relationship to the Acute Phase Reaction

  1997cited by this paper
• Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous Thrombosis

  1997cited by this paper
• Effect of Oral Contraceptives on Haemostasis Variables

  1997cited by this paper
• Risk factors for venous thrombosis: prevalence, risk, and interaction.

  1997cited by this paper
• Low dose combined oral contraceptives

  1995cited by this paper
• Low dose combined oral contraceptives

  1995cited by this paper
• Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

  1995influential reference
• Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

  1994influential reference
• New progestogens in oral contraception.

  1994cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Influence of modern low-dose oral contraceptives on hemostasis.

  1990cited by this paper
• Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause

  1985cited by this paper
• Influence of sex, blood group, secretor character, smoking habits, acetylsalicylic acid, oral contraceptives, fasting and general health state on blood coagulation variables in randomly selected young adults.

  1984cited by this paper
• A19 A29 B, and O blood-groups, Lewis blood-groups, and serum triglyceride and cholesterol concentrations in patients with venous thromboembolic disease.

  1972cited by this paper
• Oral contraceptives, venous thromboembolic disease, and ABO blood type.

  1971cited by this paper
• Venous thromboembolic disease and ABO blood type.

  1971cited by this paper
• Blood-groups and blood-clotting.

  1971cited by this paper
• ABO blood-groups and venous thromboembolism.

  1971cited by this paper
• ABO blood-groups and venous thromboembolic disease.

  1970cited by this paper
• Venous thromboembolic disease and ABO blood type.

  1969cited by this paper
• Venous thromboembolic disease and ABO blood type. A cooperative study.

  1969cited by this paper
• The Plasma Concentration of Factor VIII in the Normal Population

  1964cited by this paper

• Cerebral Venous Sinus Thrombosis During Raloxifene Therapy: A Case Report

  2025cites this paper
• The dos, don'ts, and nuances of thrombophilia testing.

  2023cites this paper
• Thrombophilia and hormonal therapy in transgender persons: A literature review and case series.

  2022cites this paper
• Lower-leg injury and knee arthroscopy have distinct effects on coagulation

  2022cites this paper
• Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability

  2019cites this paper
• Epidemiological Profile of Thrombophilia in Marrakech (Morocco): About 200 Cases

  2019cites this paper
• Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

  2017cites this paper
• Clotting factor changes during the first cycle of oral contraceptive use.

  2016cites this paper
• Cerebral venous thrombosis associated with thyrotoxicosis, the use of desmopressin and elevated factor VIII/von Willebrand factor

  2016cites this paper
• Hypertensive Crisis and Left Ventricular Thrombi after an Upper Respiratory Infection during the Long-term Use of Oral Contraceptives.

  2016influential citation
• Plasma Factor VIII Levels as a Biomarker for Venous Thromboembolism

  2015cites this paper
• Bilateral Renal Vein Thrombosis due to Elevated Factor VIII Levels.

  2015cites this paper
• EVALUATION OF ELEVATED FACTOR VIII IN ORAL CONTRACEPTIVE USERS

  2014cites this paper
• Socioeconomic Disparities in Breast Cancer Treatment Among Older Women

  2014cites this paper
• Recurrent myocardial infarctions in a young football player secondary to thrombophilia, associated with elevated factor VIII activity

  2014cites this paper
• Selection of Contraceptive Therapy for Patients with Thrombophilia: A Review of the Evidence

  2014cites this paper
• Overview and assessment of risk factors for pulmonary embolism.

  2013cites this paper
• Overview and assessment of risk factors for pulmonary embolism

  2013cites this paper
• An Integrative Approach to the Patient with Thrombophilia / SVEOBUHVATNI PRISTUP BOLESNIKU SA TROMBOFILIJOM

  2013cites this paper
• Elevated factor VIII levels and risk of venous thrombosis

  2012cites this paper
• Flow-simulated thrombin generation profiles as a predictor of thrombotic risk among pre-menopausal women

  2012cites this paper
• Kontrazeption & Thrombophilie - Eine Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e. V. und des Berufsverbands für Frauenärzte (BVF) e.V.

  2012cites this paper
• Contraception and Thrombophilia Contraception and Thrombophilia – A statement from the German Society for Gynecological Endocrinology and Reproductive Medicine ( DGGEF e . V . ) and the Professional Association of German Gynaecologists ( BVF e . V . )

  2012cites this paper
• Return of Ovulation and Menses in Postpartum Nonlactating Women: A Systematic Review

  2011cites this paper
• Contraception and Thrombophilia - A statement from the German Society for Gynecological Endo- crinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.)

  2011cites this paper
• The Risk of Venous Thrombosis, Including Cerebral Vein Thrombosis, Among Women With Thrombophilia and Oral Contraceptive Use

  2011cites this paper
• Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk

  2010cites this paper
• Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels

  2009cites this paper
• Thrombophilic conditions in the adolescent: the gynecologic impact.

  2009cites this paper
• Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.

  2009cites this paper
• Venous thromboembolism and inherited thrombophilia

  2009cites this paper
• Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)

  2009cites this paper
• Trastornos trombofílicos en la adolescente: el impacto ginecológico

  2009cites this paper
• Thrombophilia, from laboratory tests to clinical impact of single and multiple defects

  2008cites this paper
• Postpartal Right Ventricular Thrombosis

  2008cites this paper
• Venous thromboembolism in women

  2008cites this paper
• Hormone therapy and thromboembolic disease

  2007cites this paper
• Aetiology and treatment of venous thromboembolism

  2007cites this paper
• The Pathophysiology of Deep Venous Thrombosis

  2006cites this paper
• Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

  2006cites this paper
• Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review

  2005cites this paper
• Epidemiology of oral contraceptive related thrombosis.

  2005cites this paper
• The association between raised coagulation factor levels and venous thrombo-embolism.

  2005cites this paper
• Oral contraceptives, hormon er eplacement therapy ,t hrombo - philias an dr is ko fv enous thromboembolism: as ystemati cr evie w The Thrombosis: Ris ka nd Economic Assessment of Thrombophili aS creening (TREATS) Study

  2005cites this paper
• Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

  2005cites this paper
• Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis

  2005cites this paper
• Procoagulant state after raloxifene therapy in postmenopausal women.

  2005cites this paper
• Genetic polymorphisms in coagulation and fibrinolysis systems versus thromboembolic risk of estrogen-progestin therapies in women

  2005cites this paper
• Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.

  2004cites this paper
• Venous thromboembolism in menopausal period – part two

  2004cites this paper
• Hormones and pregnancy: thromboembolic risks for women

  2004cites this paper
• [High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies].

  2003cites this paper
• [A new thrombophilia risk factor: the increase of plasma factor VIII].

  2003cites this paper
• Levels of coagulation factors and venous thromboembolism

  2003cites this paper
• Factor VIII and race: a new dimension in hypercoagulability

  2003cites this paper
• Hypercoagulable state testing and malignancy screening following venous thromboembolic events

  2003cites this paper
• CASE REPORT: Elevated Factor VIII and Portal Vein Thrombosis

  2003cites this paper
• Levels of coagulation factors and venous thromboembolism.

  2003cites this paper
• Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?

  2003cites this paper
• Thrombophilias and gynaecology.

  2003cites this paper
• Elevated factor VIII and portal vein thrombosis.

  2003cites this paper
• Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis.

  2003cites this paper
• Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis

  2003cites this paper
• Élévation du facteur VIIIc coagulant et risque de thrombose veineuse : analyse critique des études cas–témoins

  2003cites this paper
• Intérêt des tests biomoléculaires dans l'exploration des maladies thrombophiliques

  2003cites this paper
• Oral Contraceptives and Inherited Thrombophilia: A Gene-Environment Interaction with a Risk of Venous Thrombosis?

  2003cites this paper
• Patent foramen ovale and cryptogenic brain infarction

  2002cites this paper
• Anomalies constitutionnelles de l'hémostase impliquées dans la thrombose veineuse

  2002cites this paper
• Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.

  2002cites this paper
• Deep vein thrombosis: clinical implications for the chiropractor. A single case study with retrospective analysis of risk factors for a patient with fatal complications

  2002cites this paper
• Female hormones and thrombosis.

  2002cites this paper
• Epidemiology of Venous Thromboembolism

  2001cites this paper
• Anticonceptivos orales y trombofilia congénita

  2001cites this paper
• T ABLE 1. C URRENT B EST E VIDENCE OF THE R ISK OF V ENOUS T HROMBOSIS AMONG A PPARENTLY H EALTHY U SERS OF A VAILABLE L OW -D OSE C OMBINED O RAL C ONTRACEPTIVES .*

  2001cites this paper
• UvA-DARE ( Digital Academic Repository ) Oral contraceptives and the risk of venous thrombosis

  2001cites this paper
• Oral contraceptives and the risk of venous thrombosis.

  2001cites this paper
• Thrombophilia: what's a practitioner to do?

  2001cites this paper
• [Oral contraceptives and congenital thrombophilia].

  2001cites this paper
• Oral Contraceptives, Hormone Replacement Therapy and Thrombosis

  2001cites this paper
• Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women.

  2001cites this paper
• Elevated Factor VIII Levels and the Risk of Thrombosis

  2001cites this paper
• Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.

  2001cites this paper
• Hypercoagulability syndromes.

  2001cites this paper
• Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.

  2001cites this paper
• Occlusive Vascular Diseases in Oral Contraceptive Users

  2000influential citation
• State-of-the-Art Review : Congenital and Acquired Thrombotic Risk Factors in Women Using Oral Contraceptives: Clinical Aspects

  2000cites this paper
• High Levels of Factor VIII and Venous Thrombosis

  2000cites this paper
• Efeitos do contraceptivo oral contendo 20 µg de etinilestradiol e 150 µg de desogestrel sobre os sistemas de coagulação e fibrinólise

  2000cites this paper
• Trombosis venosa profunda: presente y futuro

  2000cites this paper
• Die Renaissance der Einzelfaktoren: Zeigen hohe Spiegel ein höheres Risiko für venöse Thromboembolien an?. The Renaissance of Clotting Factors – Do High Levels Indicate a Higher Risk for Venous Thromboembolism?

  2000cites this paper
• Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

  2000cites this paper
• Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

  2000cites this paper
• [Deep venous thrombosis: present and future].

  2000cites this paper